Eintrag weiter verarbeiten
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?
Gespeichert in:
| Zeitschriftentitel: | International Journal of Andrology |
|---|---|
| Personen und Körperschaften: | , , , |
| In: | International Journal of Andrology, 32, 2009, 5, S. 431-441 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Corona, G. Mannucci, E. Forti, G. Maggi, M. Corona, G. Mannucci, E. Forti, G. Maggi, M. |
|---|---|
| author |
Corona, G. Mannucci, E. Forti, G. Maggi, M. |
| spellingShingle |
Corona, G. Mannucci, E. Forti, G. Maggi, M. International Journal of Andrology Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Urology Reproductive Medicine Endocrinology, Diabetes and Metabolism |
| author_sort |
corona, g. |
| spelling |
Corona, G. Mannucci, E. Forti, G. Maggi, M. 0105-6263 1365-2605 Wiley Urology Reproductive Medicine Endocrinology, Diabetes and Metabolism http://dx.doi.org/10.1111/j.1365-2605.2009.00965.x <jats:title>Summary</jats:title><jats:p>Type 2 diabetes mellitus (T2DM) is increasing at epidemic proportions worldwide, representing a risk factor for cardiovascular diseases. Nowadays, hypogonadism and erectile dysfunction (ED) are considered frequent, although often under‐diagnosed, complications of T2DM. Recent evidence suggests that in a diabetic population ED itself is an efficient predictor of silent coronary heart diseases. Patients with T2DM have an impaired sexual life, which is worsened by hypogonadism. Low T in T2DM is in fact associated with more severe ED, hypoactive sexual desire and low intercourse frequency. Testosterone replacement therapy (TRT) has been proven to improve sexual function in hypogonadal men. In addition, TRT improves adiposity, insulin resistance and total cholesterol. Specific studies on the effect of TRT in T2DM are scanty. This review will evaluate the contribution of low testosterone in diabetic subjects with sexual dysfunction. In addition, we have also reviewed available evidence on potential metabolic benefits of testosterone supplementation in T2DM patients.</jats:p> Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? International Journal of Andrology |
| doi_str_mv |
10.1111/j.1365-2605.2009.00965.x |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjYwNS4yMDA5LjAwOTY1Lng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjYwNS4yMDA5LjAwOTY1Lng |
| institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
| imprint |
Wiley, 2009 |
| imprint_str_mv |
Wiley, 2009 |
| issn |
0105-6263 1365-2605 |
| issn_str_mv |
0105-6263 1365-2605 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
corona2009followingthecommonassociationbetweentestosteronedeficiencyanddiabetesmellituscantestosteroneberegardedasanewtherapyfordiabetes |
| publishDateSort |
2009 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
International Journal of Andrology |
| source_id |
49 |
| title |
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_unstemmed |
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_full |
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_fullStr |
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_full_unstemmed |
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_short |
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_sort |
following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| topic |
Urology Reproductive Medicine Endocrinology, Diabetes and Metabolism |
| url |
http://dx.doi.org/10.1111/j.1365-2605.2009.00965.x |
| publishDate |
2009 |
| physical |
431-441 |
| description |
<jats:title>Summary</jats:title><jats:p>Type 2 diabetes mellitus (T2DM) is increasing at epidemic proportions worldwide, representing a risk factor for cardiovascular diseases. Nowadays, hypogonadism and erectile dysfunction (ED) are considered frequent, although often under‐diagnosed, complications of T2DM. Recent evidence suggests that in a diabetic population ED itself is an efficient predictor of silent coronary heart diseases. Patients with T2DM have an impaired sexual life, which is worsened by hypogonadism. Low T in T2DM is in fact associated with more severe ED, hypoactive sexual desire and low intercourse frequency. Testosterone replacement therapy (TRT) has been proven to improve sexual function in hypogonadal men. In addition, TRT improves adiposity, insulin resistance and total cholesterol. Specific studies on the effect of TRT in T2DM are scanty. This review will evaluate the contribution of low testosterone in diabetic subjects with sexual dysfunction. In addition, we have also reviewed available evidence on potential metabolic benefits of testosterone supplementation in T2DM patients.</jats:p> |
| container_issue |
5 |
| container_start_page |
431 |
| container_title |
International Journal of Andrology |
| container_volume |
32 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792339051878023171 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:41:59.708Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Following+the+common+association+between+testosterone+deficiency+and+diabetes+mellitus%2C+can+testosterone+be+regarded+as+a+new+therapy+for+diabetes%3F&rft.date=2009-10-01&genre=article&issn=1365-2605&volume=32&issue=5&spage=431&epage=441&pages=431-441&jtitle=International+Journal+of+Andrology&atitle=Following+the+common+association+between+testosterone+deficiency+and+diabetes+mellitus%2C+can+testosterone+be+regarded+as+a+new+therapy+for+diabetes%3F&aulast=Maggi&aufirst=M.&rft_id=info%3Adoi%2F10.1111%2Fj.1365-2605.2009.00965.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792339051878023171 |
| author | Corona, G., Mannucci, E., Forti, G., Maggi, M. |
| author_facet | Corona, G., Mannucci, E., Forti, G., Maggi, M., Corona, G., Mannucci, E., Forti, G., Maggi, M. |
| author_sort | corona, g. |
| container_issue | 5 |
| container_start_page | 431 |
| container_title | International Journal of Andrology |
| container_volume | 32 |
| description | <jats:title>Summary</jats:title><jats:p>Type 2 diabetes mellitus (T2DM) is increasing at epidemic proportions worldwide, representing a risk factor for cardiovascular diseases. Nowadays, hypogonadism and erectile dysfunction (ED) are considered frequent, although often under‐diagnosed, complications of T2DM. Recent evidence suggests that in a diabetic population ED itself is an efficient predictor of silent coronary heart diseases. Patients with T2DM have an impaired sexual life, which is worsened by hypogonadism. Low T in T2DM is in fact associated with more severe ED, hypoactive sexual desire and low intercourse frequency. Testosterone replacement therapy (TRT) has been proven to improve sexual function in hypogonadal men. In addition, TRT improves adiposity, insulin resistance and total cholesterol. Specific studies on the effect of TRT in T2DM are scanty. This review will evaluate the contribution of low testosterone in diabetic subjects with sexual dysfunction. In addition, we have also reviewed available evidence on potential metabolic benefits of testosterone supplementation in T2DM patients.</jats:p> |
| doi_str_mv | 10.1111/j.1365-2605.2009.00965.x |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjEzNjUtMjYwNS4yMDA5LjAwOTY1Lng |
| imprint | Wiley, 2009 |
| imprint_str_mv | Wiley, 2009 |
| institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
| issn | 0105-6263, 1365-2605 |
| issn_str_mv | 0105-6263, 1365-2605 |
| language | English |
| last_indexed | 2024-03-01T15:41:59.708Z |
| match_str | corona2009followingthecommonassociationbetweentestosteronedeficiencyanddiabetesmellituscantestosteroneberegardedasanewtherapyfordiabetes |
| mega_collection | Wiley (CrossRef) |
| physical | 431-441 |
| publishDate | 2009 |
| publishDateSort | 2009 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | International Journal of Andrology |
| source_id | 49 |
| spelling | Corona, G. Mannucci, E. Forti, G. Maggi, M. 0105-6263 1365-2605 Wiley Urology Reproductive Medicine Endocrinology, Diabetes and Metabolism http://dx.doi.org/10.1111/j.1365-2605.2009.00965.x <jats:title>Summary</jats:title><jats:p>Type 2 diabetes mellitus (T2DM) is increasing at epidemic proportions worldwide, representing a risk factor for cardiovascular diseases. Nowadays, hypogonadism and erectile dysfunction (ED) are considered frequent, although often under‐diagnosed, complications of T2DM. Recent evidence suggests that in a diabetic population ED itself is an efficient predictor of silent coronary heart diseases. Patients with T2DM have an impaired sexual life, which is worsened by hypogonadism. Low T in T2DM is in fact associated with more severe ED, hypoactive sexual desire and low intercourse frequency. Testosterone replacement therapy (TRT) has been proven to improve sexual function in hypogonadal men. In addition, TRT improves adiposity, insulin resistance and total cholesterol. Specific studies on the effect of TRT in T2DM are scanty. This review will evaluate the contribution of low testosterone in diabetic subjects with sexual dysfunction. In addition, we have also reviewed available evidence on potential metabolic benefits of testosterone supplementation in T2DM patients.</jats:p> Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? International Journal of Andrology |
| spellingShingle | Corona, G., Mannucci, E., Forti, G., Maggi, M., International Journal of Andrology, Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?, Urology, Reproductive Medicine, Endocrinology, Diabetes and Metabolism |
| title | Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_full | Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_fullStr | Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_full_unstemmed | Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_short | Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_sort | following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| title_unstemmed | Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? |
| topic | Urology, Reproductive Medicine, Endocrinology, Diabetes and Metabolism |
| url | http://dx.doi.org/10.1111/j.1365-2605.2009.00965.x |